These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12416491)

  • 1. BP drug approved for heart failure.
    Health News; 2002 Oct; 8(10):9. PubMed ID: 12416491
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sartan as a new therapy option. When heart failure patients cannot tolerate an ACE inhibitor].
    MMW Fortschr Med; 2002 Oct; 144(40):49. PubMed ID: 12440300
    [No Abstract]   [Full Text] [Related]  

  • 3. Valsartan in chronic heart failure.
    Haddy FJ
    N Engl J Med; 2002 Apr; 346(15):1173-4. PubMed ID: 11948282
    [No Abstract]   [Full Text] [Related]  

  • 4. [When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].
    MMW Fortschr Med; 2003 Dec; 145(49):18-9. PubMed ID: 14963986
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT.
    Krum H; Carson P; Farsang C; Maggioni AP; Glazer RD; Aknay N; Chiang YT; Cohn JN
    Eur J Heart Fail; 2004 Dec; 6(7):937-45. PubMed ID: 15556056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II type 1 receptor blockers and congestive heart failure.
    Auer JW; Berent R; Eber B
    Circulation; 2001 Oct; 104(15):E82. PubMed ID: 11591633
    [No Abstract]   [Full Text] [Related]  

  • 7. Ask the doctor. I have had heart failure since my heart attack a year ago. My physician initially prescribed lisinopril, an angiotensin-converting enzyme (ACE) inhibitor. Unfortunately, I was one of the unlucky people who got a cough with this drug that was so annoying I had to stop taking it. Now my doctor wants me to try a newer drug called valsartan. Is it likely to help me?
    Lee TH
    Harv Heart Lett; 2002 Jul; 12(11):8. PubMed ID: 12138046
    [No Abstract]   [Full Text] [Related]  

  • 8. [Scientific evidence--applied in routine general practice. Successful decrease in pressure and risk].
    MMW Fortschr Med; 2006 May; 148(18):42-3. PubMed ID: 16736689
    [No Abstract]   [Full Text] [Related]  

  • 9. Are angiotensin II receptor antagonists indicated in chronic heart failure?
    Komajda M
    Heart Fail Monit; 2002; 2(3):85-7. PubMed ID: 12634889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of heart failure. 2 neurohormone blockers are enough].
    MMW Fortschr Med; 2002 Sep; 144(35-36):57. PubMed ID: 12380364
    [No Abstract]   [Full Text] [Related]  

  • 12. Valsartan in chronic heart failure.
    Cayley WE
    N Engl J Med; 2002 Apr; 346(15):1173-4. PubMed ID: 11951861
    [No Abstract]   [Full Text] [Related]  

  • 13. [AT1 receptor antagonists in treatment of hypertension].
    Franz IW
    Fortschr Med; 1997 Jul; 115(19):38-40. PubMed ID: 9333581
    [No Abstract]   [Full Text] [Related]  

  • 14. [ESC guidelines for therapy of heart failure. AT1 blockers are now also included].
    MMW Fortschr Med; 2002 Jan; 144(3-4):62. PubMed ID: 11862800
    [No Abstract]   [Full Text] [Related]  

  • 15. Valsartan in chronic heart failure.
    Campbell DJ
    N Engl J Med; 2002 Apr; 346(15):1173-4. PubMed ID: 11951863
    [No Abstract]   [Full Text] [Related]  

  • 16. Valsartan in chronic heart failure.
    Forfar JC; Munir S
    N Engl J Med; 2002 Apr; 346(15):1173-4. PubMed ID: 11951862
    [No Abstract]   [Full Text] [Related]  

  • 17. Report from the 94th Cardiovascular and Renal Drugs Advisory Committee Meeting, October 11, 2001.
    Fleming T; Borer J; Lipicky R; Armstrong PW
    Circulation; 2001 Oct; 104(18):E9039. PubMed ID: 11684648
    [No Abstract]   [Full Text] [Related]  

  • 18. [New options against undertreatment].
    Pfeffer M
    MMW Fortschr Med; 2003 Dec; 145(49):18. PubMed ID: 14963987
    [No Abstract]   [Full Text] [Related]  

  • 19. How FDA currently makes decisions on clinical studies.
    Temple R
    Clin Trials; 2005; 2(4):276-81; discussion 364-78. PubMed ID: 16281425
    [No Abstract]   [Full Text] [Related]  

  • 20. Valsartan for hypertension.
    Med Lett Drugs Ther; 1997 Apr; 39(999):43-4. PubMed ID: 9137296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.